CIAPIN1 Monoclonal antibody

CIAPIN1 Monoclonal Antibody for WB, ELISA
Cat No. 68492-1-Ig

产品说明书

CloneNo. 3E7F4

宿主/亚型

Mouse / IgG1

种属反应性

Human

应用

WB, ELISA

2810413N20Rik, Anamorsin, CIAPIN1, DRE2, PRO0915

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inLNCaP cells, HeLa cells, HEK-293 cells, HepG2 cells, Jurkat cells, K-562 cells

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:5000-1:50000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

68492-1-Ig targets CIAPIN1 in WB, ELISA applications and shows reactivity with Human samples.

经测试应用 WB, ELISA Application Description
经测试反应性 Human
免疫原 CIAPIN1 fusion protein Ag33193 种属同源性预测
宿主/亚型 Mouse / IgG1
抗体类别 Monoclonal
产品类型 Antibody
全称 cytokine induced apoptosis inhibitor 1
别名 2810413N20Rik, Anamorsin, CIAPIN1, DRE2, PRO0915
计算分子量 312 aa, 34 kDa
观测分子量 37 kDa
GenBank蛋白编号BC024196
基因名称 CIAPIN1
Gene ID (NCBI) 57019
RRIDAB_3085203
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein G purification
UNIPROT IDQ6FI81
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

The cytokine-induced anti-apoptotic molecule (CIAPIN1, or DRE2) had been found to be a differentially-expressed gene involved in a variety of cancers, and it was also considered as a candidate tumor suppressor gene in gastric cancer, renal cancer and liver cancer. CIAPIN1 plays an important role in the differentiation of colorectal cancer (CRC) cells, and the differential expression of CIAPIN1 in CRC was closely related to prognosis. CIAPIN1 might play an important role in esophageal carcinogenesis, and it could be considered as a valuable prognostic indicator in esophageal squamous cell carcinoma (ESCC).

实验方案

Product Specific Protocols
WB protocol for CIAPIN1 antibody 68492-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...